Patent · US Active

Gene therapy vectors for treatment of Danon disease

US10703797B2 · kind B2 · utility

1Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 27, 2019
Grant dateJul 7, 2020
Priority date
Expiry dateDec 27, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/008
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to optimized polynucleotide sequences for LAMP-2B, expression cassettes, vectors, and methods of use thereof in treating disease, e.g. Danon disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.